Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
How do you approach patients with elevated total alkaline phosphatase levels, that is primarily from Intestine components rather than Bone or Hepatic components?
Related Questions
Do you use bone turnover markers to assess medical adherence in patients treated for osteoporosis?
Would you start romosozumab in an active smoker?
Can a 60-year-old male have a bone density test showing a normal T-score but a low Z-score?
What is your approach to IV fluid management for the treatment of hypercalcemia of malignancy?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
How do you counsel patients on the risks and benefits of strontium supplements for osteoporosis management?
How long after a successful parathyroid surgery would you reassess bone density in a patient with severe osteoporosis ?
Do you recommend the use of albumin-adjusted calcium measurement formulas to accurately assess calcium levels?
In a patient with severe osteoporosis (T-score -3.9) and multiple vertebral fractures in the setting of multiple myeloma with bone involvement, would you consider adding an anabolic agent such as romosozumab or teriparatide despite concerns about osteosarcoma risk?
Does parathyroidectomy for primary hyperparathyroidism provide metabolic benefits, such as lowering diabetes or cardiovascular disease risk?
